NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Moonlight Therapeutics

Moonlight Therapeutics

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://www.moonlighttx.com/

Last Round

VC Round

Oct 16, 2025

Total Funding Raised

$17.56M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Moonlight Therapeutics is a biotechnology company developing a platform to treat food allergies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

peanut allergy therapyfood allergy treatmentmicroneedle skin stampallergen-specific immunotherapyallergy patchpeanut patchat-home allergy treatmentintradermal immunotherapyimmunotherapy platformallergy immunotherapyAITmicroneedle drug deliverydesensitization therapyclinical-stage biotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Moonlight Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Moonlight Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Moonlight Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 16, 2025
Series ASep 12, 2024
GrantOct 16, 2023
GrantOct 16, 2023
GrantJul 10, 2023
Seed
Aug 30, 2021

Moonlight Therapeutics Investors

Notable investors and investment history

Moonlight Therapeutics investors
InvestorRounds
National Institute of Allergy and Infectious DiseasesGrant
AllerFundSeries A
Defense Health AgencyGrant
NIH RADxGrant
SeedtoB CapitalSeed
Portal InnovationsSeries A
SOSVVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 16, 2025

    SOSV participated in the funding round.

  • Sep 12, 2024

    $5M round led by AllerFund and Portal Innovations

Moonlight Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Moonlight Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Moonlight Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia
Year Founded2017
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.